GT Biopharma (GTBP) announced the appointment of Andrew Ritter to its Board of Directors. Ritter will be replacing current board member Dr. Rajesh Shrotriya, who is resigning from his position.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GTBP: